<PAGE> 1
---------------------------
OMB APPROVAL
---------------------------
- -------- OMB Number: 3235-0104
FORM 3 Expires: September 30, 1998
- -------- Estimated average burden
hours per response .... 0.5
---------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a)
of the Public Utility Holding Company Act of 1935 or Section 30(f)
of the Investment Company Act of 1940
<TABLE>
<S> <C> <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person 2. Date of Event Requiring 4. Issuer Name and Ticker or 6. If Amendment, Date
BIO-IMAGING TECHNOLOGIES INDEPENDENT Statement Trading Symbol of Original
SHAREHOLDERS COMMITTEE (Month/Day/Year) Bio-Imaging Technologies, (Month/Day/Year)
C/O BRYAN, LEVITIN & BAB, LLP 2/4/98 Inc. (BITI)
- ---------------------------------------- -------------------- ------------------------- ------------------
(Last) (First) (Middle)
330 Madison Aveunue 5. Relationship of Reporting 7. Individual or Joint/
- ---------------------------------------- 3. IRS or Social Security Person to Issuer Group Filing (Check
(Street) Number of Reporting (Check all applicable) Applicable Line)
Person (Voluntary) ___ Director X 10% Owner __ Form filed by One
New York, NY 10017 ___ Officer ___ Other Reporting Person
- -------------------------------------- ---------------------------- (give title below) (specify below) X Form filed by More
(City) (State) (Zip) than One Reporting
--------------------------- Person
- -----------------------------------------------------------------------------------------------------------------------------------
TABLE 1 -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
- -----------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Amount of Securities 3. Ownership Form: 4. Nature of Indirect
(Instr. 4) Beneficially Owned Direct (D) or Beneficial
(Instr. 4) Indirect (I) Ownership (Instr. 5)
(Instr. 5)
- -----------------------------------------------------------------------------------------------------------------------------------
Common Stock Shares
- -----------------------------------------------------------------------------------------------------------------------------------
James J. Conklin 332,200 D
- -----------------------------------------------------------------------------------------------------------------------------------
Frank J. Abella* 19,400 D
- -----------------------------------------------------------------------------------------------------------------------------------
2,332 I *Owned by a partnership of
- -----------------------------------------------------------------------------------------------------------------------------------
which Mr. Abella is Managing Partner
- -----------------------------------------------------------------------------------------------------------------------------------
J.A. Cole, Jr. 182,500 D
- -----------------------------------------------------------------------------------------------------------------------------------
Marc Berger 64,100 D
- -----------------------------------------------------------------------------------------------------------------------------------
Richard Dumler 5,000 D
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
Series A Preferred Stock
- ------------------------------------------------------------------------------------------------------------------------------------
Frank J. Abella 18,056 D
- ------------------------------------------------------------------------------------------------------------------------------------
4,666* I* *
- ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over)
(Print or Type Responses) SEC 1473 (8/92)
</TABLE>
<PAGE> 2
<TABLE>
<CAPTION>
FORM 3 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
<S> <C> <C> <C> <C> <C>
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security 2. Date 3. Title and Amount of 4. Conver- 5. Owner- 6. Nature of Indirect
(Instr. 4) Exercisable and Securities Underlying sion or ship Beneficial Ownership
Expiration Date Derivative Security Exercise Form of (Instr. 5)
(Month/Day/ (Instr. 4) Price of Deriv-
Options and warrants to Year) Common Stock Deri- ative
purchase Common Stock vative Security:
Security Direct
------------------------------------------------- (D) or
Date Expira- Amount or Indirect (I)
Exercis- tion Title Number (Instr. 5)
able Date of Shares
- ------------------------------------------------------------------------------------------------------------------------------------
James J. Conklin Current Options to 280,669 av. pr. $1.05 D
- ------------------------------------------------------------------------------------------------------------------------------------
purchase Common
- ------------------------------------------------------------------------------------------------------------------------------------
Stock
- ------------------------------------------------------------------------------------------------------------------------------------
Frank J. Abella* Current Class C warrants 66,667 .62 I *Owned by a
- ------------------------------------------------------------------------------------------------------------------------------------
to purchase Partnership
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock of which Mr.
- ------------------------------------------------------------------------------------------------------------------------------------
Abella is Managing
- ------------------------------------------------------------------------------------------------------------------------------------
Partner
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
/s/ BIO-IMAGING TECHNOLOGIES
Explanation of Responses: INDEPENDENT SHAREHOLDERS
COMMITTEE 02/24/1998
**Intentional misstatements or omissions of facts constitute Federal Criminal ------------------------------- -------------
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). **Signature of Reporting Person Date
/s/ FRANK J. ABELLA, JR
--------------------------
Frank J. Abella, Jr.
Cahirman
Note. File three copies of this Form, one of which must be manually signed. Page 2
If space provided is insufficient, See Instruction 6 for procedure. SEC 1473 (8/92)
</TABLE>
